Uptake of Gold nanoparticles in breathless (hypoxic) cancer cells

Journal of Biomedical Nanotechnology

Volumn 11, Issue 7, 2015, Pages 1162-1172

  Neshatian, Mehrnoosh ^a   Chung, Stephen ^b   Yohan, Darren ^a   Yang, Celina ^a   Chithrani, Devika B ^a  

^a RYERSON UNIVERSITY   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Cancer therapy; Gold nanoparticles; Hypoxia; Normoxia; Toxicity

Indexed keywords

FIBER OPTIC SENSORS; GOLD; METAL NANOPARTICLES; ONCOLOGY; OXYGEN; TOXICITY; TUMORS;

CANCER THERAPY; GOLD NANOPARTICLES; GOLD NANOPARTICLES (GNPS); HYPOXIA; HYPOXIC CONDITION; NORMOXIA; NORMOXIC CONDITIONS; OXYGEN CONCENTRATIONS;

DISEASES;

GOLD; METAL NANOPARTICLE; OXYGEN;

CELL FRACTIONATION; CELL HYPOXIA; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; HUMAN; MATERIALS TESTING; MCF 7 CELL LINE; METABOLISM; PHYSIOLOGY;

CELL HYPOXIA; GOLD; HELA CELLS; HUMANS; MATERIALS TESTING; MCF-7 CELLS; METAL NANOPARTICLES; OXYGEN; SUBCELLULAR FRACTIONS;

EID: 84918585613     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2015.2067     Document Type: Article

References (50)

1. B. D. Chithrani, Intracellular uptake, transport, and processing of gold nanostructures. Mol. Membr. Biol. 27, 299 (2010).
2. B. D. Chithrani, Optimization of bio-nano interface using gold nanostructures as a model nanoparticle system. Insciences J. 1, 136 (2011).
3. S. Jelveh and D. B. Chithrani, Gold nanostructures as a platform for combinational therapy in future cancer therapeutics. Cancers.Basel. 3, 1081 (2011).
4. D. B. Chithrani, Nanoparticles for improved therapeutics and imaging in cancer therapy. Recent Pat Nanotechnol. 4, 171 (2010).
5. A. G. Cuenca, H. Jiang, S. N. Hochwald, M. Delano, W. G. Cance, and S. R. Grobmyer, Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 107, 459 (2006).
6. J. Rao, Shedding light on tumors using nanoparticles. ACS Nano 2, 1984 (2008).
7. T. S. Hauck, J. L. Jennings, T. Yatsenko, J. C. Kumaradas, and W. C. W. Chan, Enhancing the toxicity of cancer chemotherapeutics with gold nanorod hyperthermia. Adv. Mater. 20, 3832 (2008).
8. B. D. Chithrani, S. Jelveh, F. Jalali, M. Van Prooijen, C. Allen, R. G. Bristow, R. P. Hill, and D. A. Jaffray, Gold nanoparticles as a radiation sensitizer in cancer therapy. Radiat. Res. 173, 719 (2010).
9. J. F. Hainfeld, D. N. Slatkin, and H. M. Smilowitz, The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 49, N309 (2004).
10. S. Jain, D. G. Hirst, and J. M. O'sullivan, Gold nanoparticles as novel agents for cancer therapy. Br. J. Radiol. 85, 101 (2012).
11. D. B. Chithrani, Cancer Nanotechnology: Principles and Applications in Radiation Oncology, edited by S. H. K. Cho, S., CRC Press, Boca Raton (2013).
12. C. Yang, M. Neshatian, M. Van Prooijen, and B. D. Chithrani, Cancer nanotechnology: Enhanced therapeutic response using peptidemodified gold nanoparticles. J. Nanosci. Nanotechnol. 14, 4813 (2014).
13. P. Vaupel, F. Kallinowski, and P. Okunieff, Blood flow, oxygen consumption and tissue oxygenation of human tumors. Adv. Exp. Med. Biol. 277, 895 (1990).
14. D. Liao and R. Johnson, Hypoxia: A key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 26, 281 (2007).
15. P. Vaupel, The role of hypoxia-induced factors in tumor progression. Oncologist 9, 10 (2004).
16. P. Carmeliet and R. K. Jain, Angiogenesis in cancer and other diseases: From genes to function to therapy. Nature 407, 249 (2000).
17. I. P. Torres-Filho, M. Leunig, F. Yuan, M. Intaglietta, and R. K. Jain, Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice. Proc. Natl Acad. Sci. USA 91, 2081 (1994).
18. G. Helmlinger, F. Yuan, M. Dellian, and R. K. Jain, Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation. Nature Med. 3, 177 (1997).
19. A. J. Primeau, A. Rendon, D. Hedley, L. Lilge, and I. F. Tannock, The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors. Clin. Cancer Res. 11, 8782 (2005).
20. P. Vaupel, K. Schlenger, C. Knoop, and M. Hockel, Oxygenation of human tumors: Evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 3316 (1991).
21. J. M. Brown and W. R. Wilson, Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 4, 437 (2004).
22. N. Chan, C. J. Koch, and R. G. Bristow, Tumor hypoxia as a modifier of DNA strand break and cross-link repair. Curr. Mol. Med. 9, 401 (2009).
23. R. P. Hill and R. G. Bristow, The Basic Science of Oncology, edited by H. R. I. F. Tannock , R. G. Bristow, and L. Harrington, McGraw- Hill Ltd., New York (2005).
24. K. R. Luoto, R. Kumareswaran, and R. G. Bristow, Tumor hypoxia as a driving force in genetic instability. Genome Integrity 4, 1 (2013).
25. R. A. Cairns, I. S. Harris, and T. W. Mak, Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85 (2011).
26. T. N. Seagroves, H. E. Ryan, H. Lu, B. G. Wouters, M. Knapp, P. Thibault, K. Laderoute, and R. S. Johnson, Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol. Cell. Biol. 21, 3436 (2001).
27. R. J. Gillies, I. Robey, and R. A. Gatenby, Causes and consequences of increased glucose metabolism of cancers. J. Nucl. Med. 49, 24S (2008).
28. H. Takagi, G. L. King, and L. P. Aiello, Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes 47, 1480 (1998).
29. A. Ouiddir, C. Planès, I. Fernandes, A. VanHesse, and C. Clerici, Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 21, 710 (1999).
30. B. D. Chithrani, J. Stewart, C. Allen, and D. A. Jaffray, Intracellular uptake, transport, and processing of nanostructures in cancer cells. Nanomedicine. NBM 5, 118 (2009).
31. B. D. Chithrani, A. A. Ghazani, and W. C. W. Chan, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662 (2006).
32. H. Gao, W. Shi, and L. B. Freund, Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 102, 9469 (2005).
33. S. Zhang, J. Li, G. Lykotrafitis, G. Bao, and S. Suresh, Sizedependent endocytosis of nanoparticles. Adv. Mater. 21, 419 (2009).
34. Y. Aoyama, T. Kanamori, T. Nakai, T. Sasaki, S. Horiuchi, S. Sando, and T. Niidome, Artificial viruses and their application to gene delivery. Size-controlled gene coating with glycocluster nanoparticles. J. Am. Chem. Soc. 125, 3455 (2003).
35. W. Jiang, B. Y. S. Kim, J. T. Rutka, and W. C. W. Chan, Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 3, 145 (2008).
36. S. Jain, J. A. Coulter, K. T. Butterworth, A. R. Hounsell, S. J. McMahon, W. B. Hyland, M. F. Muir, G. R. Dickson, K. M. Prise, F. J. Currell, D. J. Hirst, and J. M. O'Sullivan, Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions. Radiother. Oncol. 110, 342 (2014).
37. G. Frens, Controlled nucleation for the particle size in monodisperse gold suspensions. Nature 241, 20 (1973).
38. S. O. P. Cristiana, M. M. Lino, A. A. Matos, and L. S. Ferreira, Differential internalization of amphotericin B e conjugated nanoparticles in human cells and the expression of heat shock protein 70. Biomater. 34, 5281 (2013).
39. B. J. Moeller, R. A. Rachel, A. Richardson, and M. W. Dewhirst, Hypoxia and radiotherapy: Opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev. 26, 241 (2007).
40. S. Dische, P. J. Anderson, R. Sealy, and E. R. Watson, Carcinoma of the cervix-anaemia, radiotherapy and hyperbaric oxygen. Br. J. Radiol. 56, 251 (1983).
41. R. Sullivan, G. C. Paré, L. J. Frederiksen, G. L. Semenza, and C. H. Graham, Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity. Mol. Cancer Ther. 7, 1961 (2008).
42. R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R. R. Bhonde, and M. Sastry, Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview. Langmuir 21, 10644 (2005).
43. B. D. Chithrani and W. C. W. Chan, Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 7, 1542 (2007).
44. L. Hu, Z. Mao, Y. Zhang, and C. Gao, Influences of size of silica particles on the cellular endocytosis, exocytosis and cell activity of HepG2 cells. J. Nanosci. Lett. 1, 1 (2011).
45. C. F. Tormena, V. Lacerda, Jr., and K. T. de Oliveira, Revisiting the stability of endo/exo diels-alder adducts between cyclopentadiene and 1, 4-benzoquinone. J. Braz. Chem. Soc. 21, 112 (2010).
46. J. Panyam and L. Labhasetwar, Dynamics of endocytosis and exocytosis of poly(D, L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm. Res. 20, 212 (2003).
47. H. Shorer, N. Amar, A. Meerson, and Z. Elazar, Modulation of N-ethylmaleimidesensitive factor activity upon amino acid deprivation. J. Biol. Chem. 280, 16219 (2005).
48. G. Bellot, R. Garcia-Medina, P. Gounon, J. Chiche, D. Roux, J. Pouysseegur, and N. M. Mazure, Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 29, 2570 (2009).
49. X. Ma, Y. Wu, S. Jin, Y. Tian, X. Zhang, Y. Zhao, L. Yu, and X.-J. Liang, Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano 5, 8629 (2011).
50. I. F. Tannock and D. Rotin, Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49, 4373 (1989).